Allergan Sold to Actavis for $66 Billion

By |2016-12-23T12:42:21-07:00November 19th, 2014|News|

Allergan, the maker of Botox, sold yesterday for a reported $66 billion. The move by Ireland's Actavis Plc marked the end of a hostile pursuit of Allergan by William Ackman and Valeant Pharmaceuticals International Inc. Allergan had resisted the takeover by Valeant on the grounds that it would hurt its shareholders, given the Canadian pharma company's [...]